Light Mode
$9.40 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.40, $11.10 below the day’s high of $20.50
-15.60 (-62.40%) / 6M
Momentum, market sentiment, and recent alerts
PTHS reads poor: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is -72.5%.
No alerts for PTHS in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform "Nitricil". Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.